Glaucoma is characterized by a continuous loss of retinal ganglion cells. The cause of glaucoma is associated with an increase in intraocular pressure (IOP), but the underlying pathophysiology is diverse and, in most cases, unknown. There is an indisputable unmet need to identify new pathways involved in glaucoma pathogenesis. Increasing evidence suggests that bioactive lipids may be critical in the development and progression of glaucoma. Preclinical and clinical bioactive lipid targets exist and are being developed. In this review, we aim to shed light on the potential of bioactive lipids for the prevention, diagnosis, prognosis, and treatment of glaucoma by asking the question "is fat the future for saving sight". Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Miriam Kolko, Zaynab Ahmad Mouhammad, Barbara Cvenkel. Is fat the future for saving sight? Bioactive lipids and their impact on glaucoma. Pharmacology & therapeutics. 2023 May;245:108412
PMID: 37037408
View Full Text